VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,730,447 | -71.3% | 64,305 | -67.9% | 0.03% | -69.9% |
Q2 2023 | $6,024,230 | +350757.9% | 200,074 | +277.0% | 0.10% | +194.3% |
Q1 2023 | $1,717 | +354.2% | 53,066 | +302.7% | 0.04% | +250.0% |
Q4 2022 | $378 | -99.9% | 13,177 | +0.2% | 0.01% | 0.0% |
Q3 2022 | $317,000 | -5.9% | 13,150 | +7.0% | 0.01% | 0.0% |
Q2 2022 | $337,000 | -28.5% | 12,291 | 0.0% | 0.01% | -28.6% |
Q1 2022 | $471,000 | +16.9% | 12,291 | -2.4% | 0.01% | +16.7% |
Q4 2021 | $403,000 | -4.5% | 12,591 | -12.1% | 0.01% | -14.3% |
Q3 2021 | $422,000 | -70.5% | 14,331 | -60.8% | 0.01% | -84.1% |
Q3 2020 | $1,431,000 | +265.1% | 36,543 | +241.5% | 0.09% | +214.3% |
Q2 2020 | $392,000 | -96.2% | 10,700 | -97.0% | 0.03% | -96.8% |
Q4 2019 | $10,299,000 | +128.0% | 351,727 | +108.0% | 0.87% | +71.1% |
Q3 2019 | $4,517,000 | +120.0% | 169,105 | +121.4% | 0.51% | +88.8% |
Q2 2019 | $2,053,000 | +2.6% | 76,371 | -14.4% | 0.27% | -20.6% |
Q1 2019 | $2,000,000 | – | 89,203 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |